Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancerNature CommunicationsApril 13, 202310.1038/s41467-023-37727-yCited by 54SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis